Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (521-530 of 684) with videos related to

Pageof 69
Sort By:
The American Journal of Clinical Nutrition|February 8, 2025
Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association ConsortiumChristina M Nagle, Torukiri I Ibiebele, Renhua Na, et al.
Clinical Epigenetics|July 30, 2025
Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinomaChristelle Colin-Leitzinger, Katherine A Lawson-Michod, Courtney E Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2022
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancerJ E Berchuck, F Facchinetti, D F DiToro, et al.
Nature Medicine|August 15, 2017
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitorsHana Janouskova, Geniver El Tekle, Elisa Bellini, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profilingSimon Garinet, Karl Semaan, Jiao Li, et al.
The Journal of Clinical Investigation|February 2, 2026
Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinomaSimon Garinet, Karl Semaan, Jiao Li, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association ConsortiumHolly R Harris, Ana Babic, Penelope M Webb, et al.
Pageof 69

Showing results (521-530 of 684) with videos related to

Sort By:
Pageof 69
The American Journal of Clinical Nutrition|February 8, 2025
Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association ConsortiumChristina M Nagle, Torukiri I Ibiebele, Renhua Na, et al.
Clinical Epigenetics|July 30, 2025
Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinomaChristelle Colin-Leitzinger, Katherine A Lawson-Michod, Courtney E Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2022
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancerJ E Berchuck, F Facchinetti, D F DiToro, et al.
Nature Medicine|August 15, 2017
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitorsHana Janouskova, Geniver El Tekle, Elisa Bellini, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profilingSimon Garinet, Karl Semaan, Jiao Li, et al.
The Journal of Clinical Investigation|February 2, 2026
Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinomaSimon Garinet, Karl Semaan, Jiao Li, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association ConsortiumHolly R Harris, Ana Babic, Penelope M Webb, et al.
Pageof 69